Skip to Main Content

Paper Details

Immunosuppressive treatment and the risk of diabetes in rheumatoid arthritis.
PLoS One
30
2019
DMARD, Hydroxychloroquine, Patients, RA, TNF, diabetes, disease, hydroxychloroquine, methotrexate, obesity, patients, rheumatoid arthritis
Author NameAffiliation
Jeffrey D GreenbergNYU Hospital for Joint Diseases
Marc C HochbergUniversity of Maryland School of Medicine
Joel M KremerAlbany Medical College and The Center for Rheumatology
  • 1 - 3

Datasets

Release 1.2